Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock

Annals of Pharmacotherapy

Volumn 44, Issue 10, 2010, Pages 1545-1553

  Rodríguez Núñez, Antonio ^a   Oulego Erroz, Ignacio ^a   Gil Antón, Javier ^b   Pérez Caballero, César ^c   López Herce, Jesús ^d   Gaboli, Mireia ^e   Milano, Guillermo ^f  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL SAN RAFAEL   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^f HOSPITAL MATERNO INFANTIL   (Spain)

Author keywords

Children; Continuous infusion; Critical care; Rescue therapy; Septic shock; Terlipressin

Indexed keywords

ADRENALIN; NORADRENALIN; TERLIPRESSIN;

ADOLESCENT; AMPUTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DOSE TITRATION; ELECTROLYTE DISTURBANCE; FEMALE; HEART ARREST; HEMODYNAMIC MONITORING; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; INFANT; INTENSIVE CARE UNIT; ISCHEMIA; LIMB ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; NEWBORN; OLIGURIA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOLYSIS; RISK FACTOR; SCHOOL CHILD; SEPTIC SHOCK; SIDE EFFECT; URINE VOLUME;

ADOLESCENT; BLOOD PRESSURE; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HEMODYNAMICS; HOSPITALS, UNIVERSITY; HUMANS; HYPOTENSION; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS, PEDIATRIC; ISCHEMIA; LYPRESSIN; MALE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SPAIN; SURVIVAL RATE; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 77957671710     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P254     Document Type: Article

References (35)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003;167:695-701.
2. Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009;37:666-88.
3. De Oliveira CF, De Oliveira DS, Gottschald AF, et al. ACCM/PALS haemodynamic support guidelines for pediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med 2008;34:1065-75.
4. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95.
5. Farand P, Hamel M, Lauzier F, Plante GE, Lesur O. Review article: organ perfusion/permeability-related effects of norepinephrine and vasopressin in sepsis. Can J Anaesth 2006;53:934-46.
6. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-10.
7. Matok I, Vard A, Efrati O, et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 2005;23:305-10.
8. Rodríguez-Núñez A, López-Herce J, Gil-Antón J, Hernández A, Rey C; RETSPED Working Group of the Spanish Society of Pediatric Intensive Care. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care 2006;10:R20.
9. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-82.
10. Leone M, Albanèse J, Delmas A, Chaabane W, Garnier F, Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004;22:314-9.
11. Dünser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-9.
12. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87.
13. Choong K, Bohn D, Fraser DD, et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med 2009;180:632-9.
14. Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 2008;34:511-7.
15. Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009;37:811-8.
16. Lauzier F, Lévy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 2005;32:1782-9.
17. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003;31:2646-50.
18. Meyer S, Gortner L, McGuire W, Baghai A, Gottschling S. Vasopressin in catecholamine-refractory shock in children. Anaesthesia 2008;63:228-34.
19. Rodríguez-Núñez A, Fernández-Sanmartín M, Martinón-Torres F, González-Alonso N, Martinón- Sánchez JM. Terlipressin for catecholamineresistant septic shock in children. Intensive Care Med 2004;30:477-80.
20. Salluh JI, Martins GA, Santino MS, Araújo LV, Freitas GG, Verdeal JC. Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury. Acta Anaesthesiol Scand 2007;51:505-8.
21. Rehberg S, Ertmer C, Köhler G, et al. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock. Intensive Care Med 2009;35:1286-96.
22. Westphal M, Rehberg S, Ertmer C, Morelli A. Terlipressin - more than just a prodrug of lysine vasopressin? Crit Care Med 2009;37:1135-6.
23. Morelli A, Ertmer C, Rehberg S, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 2009;13:R130.
24. Mégarbané H, Barete S, Khosrotehrani K, et al. Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin). Dermatology 2009;218:334-7.
25. Ertmer C, Rehberg S, Westphal M. Vasopressin analogues in the treatment of shock states: potential pitfalls. Best Pract Res Clin Anaesthesiol 2008;22:393-406.
26. Lange M, Morelli A, Ertmer C, et al. Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 2007;28:623-9.
27. Morelli A, Ertmer C, Lange M, Westphal M. Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med 2007;33:1669-70.
28. Michel F, Thomachot L, David M, et al. Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock. Am J Emerg Med 2007;25:863.e1-2.
29. Zeballos G, López-Herce J, Fernández C, Brandstrup KB, Rodríguez-Núñez A. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation 2006;68:151-3.
30. Pappof P, Mancuso M, Barbara CS, Moretti C. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience. Int J Immnunopathol Pharmacol 2007;20:213-21.
31. Ministry of Health: Royal Decree 223/2004, of February 6th, that regulates clinical trials with drugs. BOE (Official State Bulletin). Madrid, Spain. 2004;33:5429-43.
32. Albanèse J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005;33:1897-902.
33. Luckner G, Dünser M, Jochberger S, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005;33:2659-66.
34. Singer M. Arginine vasopressin vs terlipressin in the treatment of shock states. Best Practice Res Clin Anaesth 2008;22:359-68.
35. Maclaren G, Butt W, Best D, Donath S, Taylor A. Extracorporeal membrane oxygenation for refractory septic shock in children: one institution's experience. Pediatr Crit Care Med 2007;8:447-51.